Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Accounts Payables: 2021-2024

Historic Accounts Payables for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $11.4 million.

  • Prime Medicine's Accounts Payables rose 72.30% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 72.30%. This contributed to the annual value of $11.4 million for FY2024, which is 41.90% down from last year.
  • Per Prime Medicine's latest filing, its Accounts Payables stood at $11.4 million for FY2024, which was down 41.90% from $19.5 million recorded in FY2023.
  • Prime Medicine's Accounts Payables' 5-year high stood at $19.5 million during FY2023, with a 5-year trough of $1.4 million in FY2021.
  • Moreover, its 3-year median value for Accounts Payables was $11.4 million (2024), whereas its average is $11.7 million.
  • Per our database at Business Quant, Prime Medicine's Accounts Payables skyrocketed by 350.99% in 2023 and then slumped by 41.90% in 2024.
  • Prime Medicine's Accounts Payables (Yearly) stood at $1.4 million in 2021, then spiked by 201.88% to $4.3 million in 2022, then soared by 350.99% to $19.5 million in 2023, then slumped by 41.90% to $11.4 million in 2024.